m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs

Area of Science:

• Molecular Biology
• Cell Biology
• Pathology

Background:

• Organ fibrosis is a major cause of organ damage and failure.
• Chronic tissue injury triggers fibrotic responses in organs like the lung, liver, kidney, and heart.
• N6-methyladenosine (m6A) RNA modification is increasingly recognized for its role in various biological processes.

Purpose of the Study:

• To comprehensively review the current understanding of m6A RNA modification in organ fibrosis.
• To elucidate the mechanisms and functions of m6A in the pathogenesis of fibrotic diseases.
• To identify m6A as a potential therapeutic target for organ fibrosis.

Main Methods:

• Literature review of recent studies on m6A RNA modification and organ fibrosis.
• Analysis of experimental data and research findings from diverse organ systems.
• Synthesis of information on molecular mechanisms and clinical implications.

Main Results:

• m6A RNA modification plays a significant regulatory role in the development and progression of fibrosis in multiple organs.
• Specific m6A regulators and target genes are implicated in fibrotic pathways.
• Evidence suggests m6A modification influences key cellular processes involved in fibrosis, such as inflammation, cell proliferation, and extracellular matrix deposition.

Conclusions:

• m6A RNA modification is a critical factor in organ fibrosis.
• Targeting m6A pathways offers a promising therapeutic strategy for treating fibrotic diseases.
• Further research into m6A modification is warranted to advance clinical treatments for organ fibrosis.